The 13th Annual
Pre-Filled Syringes East Coast Conference will return to Boston in April 2026, continuing as a premier event for the latest innovations in injectable drug delivery.
As part of our leading
PFS Series, the 2026 conference will once again bring together top experts, industry leaders, and innovators for a three-days of key insights and networking. The conference will feature a comprehensive pre-conference focus day dedicated to advancements in device design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the most pressing industry challenges and breakthrough solutions:
- Device Innovations for Large Volume and Novel Drug Product Delivery
- Advancing Sustainability in the Injectable Device Industry
- Primary Packaging: Ensuring Safe, Stable, and Biocompatible Combination Products
- Patient-Driven Device Design
What attendees can expect:
- FREE Attendance for Pharma & Biotech Experts*
- Dedicated Content Streams & Interactive Roundtables
- 400+ Attendees
- 65+ Big Pharma & Biotech Companies in the Room
- 35+ Exhibitors & Sponsors
- 40+ Expert Speakers From the Likes Of:
- AstraZeneca | Eli Lilly | Genentech | Biogen | Merck | Gilead | Pfizer | Takeda | Bristol Myers Squibb
- Johnson & Johnson | AbbVie | Kailera Therapeutics | Teva Pharmaceuticals | Alexion | Astria Therapeutics | Ionis Pharmaceuticals … and many more!
This must-attend event provides invaluable insights for professionals looking to enhance their injectable device portfolios while fostering meaningful connections with key stakeholders across the field. We look forward to welcoming you to Boston in April 2026!
Confirmed Speakers Include:
- Aditya Sukthankar, Associate Director - GRA Device Lead - Specialty Care Devices and Combination products, Sanofi
- Adrienne Fletcher, Director, Packaging and Device Strategy and Innovation, Johnson & Johnson
- Alicia Douglas, Human Factors Lead, Principal Scientist, Merck
- Althena Medical - Senior Representative, Althena Medical
- Amardeep Hoonjan, Director Device R&D Lead, Biocompatibility Group, AbbVie
- Amey Mathakari, Senior Engineer II, Alexion, AstraZeneca Rare Disease
- Amin Sedighiamiri, Senior Director, Device Development and Technology, Merck
- Amy Wise, Associate Director, RA Emerging Technologies, Combination Products, and Devices, AbbVie
- Ashish Pokharel, Senior Device Engineer, AstraZeneca
- Brittany Conrad, Senior Human Factors Engineer, Pfizer Inc.
- Cambridge Design Partnership Ltd - Senior Representative, Cambridge Design Partnership Ltd
- CCL Healthcare - Senior Representative, CCL Healthcare
- Christina Van Geen Hoven, Director and Portfolio Project Lead, Pfizer
- Chuck Ventura, Chief Executive Officer, Ventura Solutions
- Credence MedSystems, Inc. - Senior Representative, Credence MedSystems, Inc.
- Crux Product Design - Senior Representative, Crux Product Design
- David Vazquez, Sr Director of Digital & Device Technical Operations, Pfizer
- Doug Bakan, Chief Technology Officer, Kailera Therapeutics
- Duncan Paterson, Senior Director, AstraZeneca, Representing the Subcutaneous Drug Development & Delivery Consortium
- EdgeOne Medical - Senior Representative, EdgeOne Medical
- Edward Hatton, Director Quality Assurance, External Manufacturing, Amneal Pharmaceuticals
- Ellie Rundell, Usability Leader, Sanofi
- Gerresheimer - Senior Representative, Gerresheimer
- Gretchen Piwinski, Sr Manager Combination Product Development, Regeneron
- Haselmeier GmbH - Senior Representative, Haselmeier GmbH
- Instron - Senior Representative, Instron
- Javad Eshraghi, Senior Advisor, Eli Lilly and Company
- Jayne Gavrity, Senior Device Engineer, AstraZeneca
- Johanna Schoss, Principal Human Factors Engineer, Biogen
- Kevin Maloney, Senior Director, Biologics Drug Product Development, Biogen
- Khaudeja Bano, Vice President - Global Head of Device Quality, Roche-Genentech
- Kindeva - Senior Representative, Kindeva
- Kinsuk Shah, Sr. AD Combination Product Steward, Boehringer Ingelheim
- Lisa Ray, Executive Director Program Management - Delivery, Device & Connected Solutions, Eli Lilly and Company
- Mark DeStefano, Global Technology Innovation, Combination Products and Device Research & Development, Teva Pharmaceuticals
- Mark Howansky, VP, Device Development & Commercialization, Viridian Therapeutics
- Mayumi Bowen, Senior Principal Engineer, Genentech, A Member of the Roche Group
- Merin Kalapurackal, Engineer, Device Development, Bristol Myers Squibb
- Mitsubishi Gas Chemical Company, Inc - Senior Representative, Mitsubishi Gas Chemical Company, Inc
- Monica Swinney, Sr. Director & Head, Drug Delivery Innovation & New Product Planning, Gilead Sciences
- Ning Yu, Vice President, Device and Combination Product Development, Astria Therapeutics
- Prasad Peri, AVP Regualtory Affairs Connected Delivery, Devices and Digital Health, Eli Lilly
- Richard Braga, Device SRM/CDMO Lead, Takeda Pharmaceuticals
- Roy Wang, Associate Director, Device Development & Manufacturing, Viridian Therapeutics
- Schreiner MediPharm - Senior Representative, Schreiner MediPharm
- Senior Representative, Immunovant
- Sharmad Joshi, Senior Engineer II Device Development, Alexion
- Shirish Ingawale, Director, Device & Combination Product Development, Takeda Pharmaceutical Company Limited
- SHL Medical - Senior Representative, SHL Medical AG
- Shruti Parikh, Director, Product Design, Takeda
- Sriram Natarjaan, Sr. Manager, Product Quality Management, Johnson & Johnson
- Stevanato Group - Senior Representative, Stevanato Group
- Subhi Saadeh, Associate Director - MDCP QA, Gilead
- Sujit Basu, Vice President & Head, Pharmaceutical Development, Ionis Pharmaceuticals
- Suttons Creek - Senior Representative, Suttons Creek
- Theresa Scheuble, Director R&D Drug Delivery Systems, Johnson & Johnson
- West Pharmaceutical Services - Senior Representative, West Pharmaceutical Services
- Zeon - Senior Representative, Zeon
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Sheraton Boston Hotel
39 Dalton Street,
Boston, MA, USA
